The First Two Imported Cases of SARS-CoV-2 Omicron Variant - Tianjin Municipality, China, December 13, 2021

被引：26

作者：

Tan, Zhaolin ^{[1
]}

Chen, Zhixiao ^{[2
]}

Yu, Aiping ^{[1
]}

Li, Xiaoyan ^{[1
]}

Feng, Yenan ^{[2
]}

Zhao, Xiang ^{[2
]}

Xu, Wenbo ^{[2
]}

Su, Xu ^{[1
]}

机构：

[1] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China

[2] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China

来源：

CHINA CDC WEEKLY | 2022年 / 4卷 / 04期

关键词：

D O I：

10.46234/ccdcw2021.266

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：76 / 77

页数：2

共 7 条

[1]

GISAID, 2021, TRACK VAR 2021

[2]

National Institute for Communicable Diseases, 2021, DAIL COVID 19 EFF RE

[3]

Sadek A, 2021, STRUCTURAL INSIGHTS, V1, P18, DOI [10.1101/2021.12.08.471777, DOI 10.1101/2021.12.08.471777]

[4]

Schmidt Fabian, 2021, medRxiv, DOI 10.1101/2021.12.12.21267646

[5]

Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61

[6]

UK Health Security Agency, 2021, SARS COV 2 VAR VAR I

[7]

Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI [10.1056/NEJMoa2001017, 10.1172/JCI89857]